| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 956.7MM | -0% |
| Gross Profit | 669.5MM | +1% |
| Cost Of Revenue | 287.2MM | -3% |
| Operating Income | 171.5MM | +3% |
| Operating Expenses | 498MM | +0% |
| Net Income | 124MM | +2% |
| R&D | 82.2MM | -7% |
| G&A | 402.5MM | -1% |
| Amortization | 4MM | -5% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Align Technology's (ALGN) first quarter 2024 revenue growth was up across all regions and was driven by strong Clear Aligner volumes, primarily in the Asia Pacific region.
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Q1 2024 Align Technology Inc Earnings Call
Align Technology reports a solid revenue increase and strategic advancements in its Q1 2024 earnings, with a positive outlook for the fiscal year.
ALGN earnings call for the period ending March 31, 2024.
Align Technology Reports Modest Revenue Growth but Misses EPS Estimates
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Align Technology (ALGN) delivered earnings and revenue surprises of 8.08% and 2.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
TEMPE, Ariz., April 24, 2024--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'24"). Q1'24 total revenues were $997.4 million, up 4.3% sequentially and up 5.8% year-over-year. Q1'24 Clear Aligner revenues were $817.3 milli
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.